A new rule would base the price Medicare pays for certain drugs on the lowest price paid among similar countries. But a rushed process means legal challenges are likely.
A new rule would base the price Medicare pays for certain drugs on the lowest price paid among similar countries. But a rushed process means legal challenges are likely.